Mesothelioma Hub is a trusted resource dedicated to supporting those affected by mesothelioma. Our team of medical and legal experts bring insightful, reliable, and recent information on mesothelioma healthcare, from survivor stories and medical breakthroughs to guidance on treatment options and connecting with specialists.
On September 17, 2024, the Food and Drug Administration (FDA) approved Keytruda (pembrolizumab), in combination with pemetrexed and platinum-based chemotherapy, as a first-line treatment for unresectable advanced or metastatic malignant pleural mesothelioma (MPM). Keytruda is an immunotherapy drug that helps the immune system recognize and kill cancer cells by [...]
